Merck KGaA: Karl-Ludwig Kley Named Executive Board Deputy Chairman
Kley will be responsible for the integration of Schering AG, Berlin. Merck announced earlier its decision to make a public takeover of Schering, offering its shareholders EUR 77 in cash per share.
Kley has been a member of the Executive Board at Deutsche Lufthansa AG since 1998 and a member of the Supervisory Board of Merck KGaA as well as the Advisory Board of E. Merck OHG since 2004. The latter company oversees the 73% stake the Merck family holds in Merck KGaA. Before moving to Lufthansa, Kley held various leadership positions at Bayer AG in Leverkusen, Germany. There he led the pharma business's sales and marketing operations in Africa, Asia and Latin America before taking over responsibility for corporate finance and investor relations. During his time at Bayer, he also spent eight years abroad, in Japan and Italy, Kley completed his law degree in 1979 at the University of Munich and then went on to obtained a PhD.
The position of deputy chairman of the executive board has remained vacant since Dr. Michael Roemer was named chairman of the board in November 2005.
Most read news
Other news from the department people
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.